We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMCSA icon
176
Comcast
CMCSA
$85.8B
$15.9M 0.13%
316,424
+4
+0% +$211
VRSK icon
177
Verisk Analytics
VRSK
$27.8B
$15.9M 0.13%
79,544
– –
ACAD icon
178
Acadia Pharmaceuticals
ACAD
$4.45B
$15.3M 0.13%
298,888
– –
NEO icon
179
NeoGenomics
NEO
$1.74B
$15.3M 0.13%
296,519
-9
-0% -$469
TTEK icon
180
Tetra Tech
TTEK
$8.7B
$15.3M 0.13%
686,800
+25
+0% +$662
HASI icon
181
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.95B
$15M 0.13%
246,602
-1
-0% -$60
INFO
182
DELISTED
IHS Markit Ltd. Common Shares
INFO
$14.9M 0.12%
173,107
– –
MGNX icon
183
MacroGenics
MGNX
$245M
$14.8M 0.12%
676,130
+5
+0% +$121
PNC icon
184
PNC Financial Services
PNC
$100B
$14.8M 0.12%
103,458
– –
IBM icon
185
IBM
IBM
$214B
$14.6M 0.12%
126,349
+2
+0% +$239
NTRS icon
186
Northern Trust
NTRS
$22.2B
$14.6M 0.12%
162,673
-14
-0% -$1.37K
GWPH
187
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$14.5M 0.12%
130,547
– –
CHD icon
188
Church & Dwight Co
CHD
$23.7B
$14.3M 0.12%
170,188
– –
FFIV icon
189
F5
FFIV
$22.8B
$14.2M 0.12%
84,236
– –
PH icon
190
Parker-Hannifin
PH
$125B
$14.2M 0.12%
54,412
+8
+0% +$2.31K
KPTI icon
191
Karyopharm Therapeutics
KPTI
$161M
$14.1M 0.12%
63,438
-1
-0% -$211
MET icon
192
MetLife
MET
$62.7B
$14M 0.12%
311,129
+1
+0% +$55
CHTR icon
193
Charter Communications
CHTR
$16.7B
$14M 0.12%
22,061
– –
IBN icon
194
ICICI Bank
IBN
$109B
$14M 0.12%
979,441
– –
TJX icon
195
TJX Companies
TJX
$178B
$13.9M 0.12%
212,372
– –
ITCI
196
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$13.9M 0.12%
456,022
– –
ADP icon
197
Automatic Data Processing
ADP
$106B
$13.8M 0.12%
81,676
– –
TAL icon
198
TAL Education Group
TAL
$5.79B
$13.8M 0.11%
200,812
– –
FOLD
199
DELISTED
Amicus Therapeutics
FOLD
$13.6M 0.11%
615,124
– –
LULU icon
200
lululemon athletica
LULU
$13.7B
$13.6M 0.11%
40,784
– –
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.